Pre-treatment DPYD genetic tes

Pre-treatment DPYD genetic testing for patients who are prescribed chemotherapy involving fluoropyrimidines – SHTG Assessment

Harbour J

Record ID 32018000858

English

Details

Project Status: Completed

URL for project: http://www.healthcareimprovementscotland.org/our_work/technologies_and_medicines/topics_assessed/assessment_04-20.aspx

URL for protocol: http://www.healthcareimprovementscotland.org/our_work/technologies_and_medicines/topics_assessed/assessment_04-20.aspx

Year Published: 2020

URL for published report: http://www.healthcareimprovementscotland.org/our_work/technologies_and_medicines/topics_assessed/assessment_04-20.aspx

Requestor: NHS National Services Scotland

English language abstract: An English language summary is available

Publication Type: Rapid Review

Country: Scotland, United Kingdom

MeSH Terms

Pharmacogenomic Testing
Genetic Testing
Antineoplastic Combined Chemotherapy Protocols
Pyrimidines
Neoplasms
Precision Medicine

Keywords

DYPD
dihydropyrimidine dehydrogenase
fluoropyrimidines

Contact

Organisation Name: Scottish Health Technologies Group

Contact Address: Scottish Health Technologies Group, Delta House, 50 West Nile Street, Glasgow, G1 2NP Tel: 0141 225 6998

Contact Name: his.shtg@nhs.scot

Contact Email: his.shtg@nhs.scot

Copyright: Healthcare Improvement Scotland

This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.